[go: up one dir, main page]

WO2008122667A3 - Ureylene derivatives - Google Patents

Ureylene derivatives Download PDF

Info

Publication number
WO2008122667A3
WO2008122667A3 PCT/EP2008/054362 EP2008054362W WO2008122667A3 WO 2008122667 A3 WO2008122667 A3 WO 2008122667A3 EP 2008054362 W EP2008054362 W EP 2008054362W WO 2008122667 A3 WO2008122667 A3 WO 2008122667A3
Authority
WO
WIPO (PCT)
Prior art keywords
ureylene
derivatives
compounds
therapy
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/054362
Other languages
French (fr)
Other versions
WO2008122667A2 (en
Inventor
John Edward Moses
Stephen Neidle
Adam Donald Moorhouse
Michael Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of WO2008122667A2 publication Critical patent/WO2008122667A2/en
Publication of WO2008122667A3 publication Critical patent/WO2008122667A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns compounds of Formula (I) or a salt, solvate or pro-drug thereof. The compounds may be used in therapy, particularly anti-cancer therapy.
PCT/EP2008/054362 2007-04-10 2008-04-10 Ureylene derivatives Ceased WO2008122667A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0706932.1 2007-04-10
GBGB0706932.1A GB0706932D0 (en) 2007-04-10 2007-04-10 Ureylene derivatives

Publications (2)

Publication Number Publication Date
WO2008122667A2 WO2008122667A2 (en) 2008-10-16
WO2008122667A3 true WO2008122667A3 (en) 2009-04-09

Family

ID=38091133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/054362 Ceased WO2008122667A2 (en) 2007-04-10 2008-04-10 Ureylene derivatives

Country Status (2)

Country Link
GB (1) GB0706932D0 (en)
WO (1) WO2008122667A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010138079A (en) * 2008-12-09 2010-06-24 Mitsui Chemicals Inc Amide derivative and insecticide
GB201105751D0 (en) * 2011-04-05 2011-05-18 Univ London Pharmacy G-quadruplex stabilising agent
US10738016B2 (en) 2015-10-13 2020-08-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. BRD4-kinase inhibitors as cancer therapeutics
CN117902994A (en) * 2023-12-06 2024-04-19 中山海泓药业有限公司 Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid
CN118290341B (en) * 2024-03-29 2024-10-18 国王医学科技(山东)有限公司 Urea compound with anti-tumor activity, preparation method and application

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116729A2 (en) * 1983-01-24 1984-08-29 Duphar International Research B.V Benzoylurea compounds and pesticidal compositions comprisingsame
JPS6434953A (en) * 1987-07-30 1989-02-06 Agro Kanesho Co Ltd Benzoylurea based compound and acaricide and insecticide containing said compound as active ingredient
WO2000042012A1 (en) * 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
WO2004007437A1 (en) * 2002-07-11 2004-01-22 Aventis Pharma Deutschland Gmbh Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
FR2850970A1 (en) * 2003-02-07 2004-08-13 Aventis Pharma Sa New quaternary aromatic nitrogen heterocycle derivatives that fix the G-quadruplex structure of DNA or RNA are telomerase inhibitors, useful in the treatment of cancers and some genetic disorders
WO2005051366A2 (en) * 2003-11-28 2005-06-09 Novartis Ag Diaryl urea derivatives in the treatment of protein kinase dependent diseases
WO2006049941A2 (en) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl ureas as cb1 antagonists
EP1724258A1 (en) * 2004-02-23 2006-11-22 Chugai Seiyaku Kabushiki Kaisha Heteroarylphenylurea derivative

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116729A2 (en) * 1983-01-24 1984-08-29 Duphar International Research B.V Benzoylurea compounds and pesticidal compositions comprisingsame
JPS6434953A (en) * 1987-07-30 1989-02-06 Agro Kanesho Co Ltd Benzoylurea based compound and acaricide and insecticide containing said compound as active ingredient
WO2000042012A1 (en) * 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
WO2004007437A1 (en) * 2002-07-11 2004-01-22 Aventis Pharma Deutschland Gmbh Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
FR2850970A1 (en) * 2003-02-07 2004-08-13 Aventis Pharma Sa New quaternary aromatic nitrogen heterocycle derivatives that fix the G-quadruplex structure of DNA or RNA are telomerase inhibitors, useful in the treatment of cancers and some genetic disorders
WO2005051366A2 (en) * 2003-11-28 2005-06-09 Novartis Ag Diaryl urea derivatives in the treatment of protein kinase dependent diseases
EP1724258A1 (en) * 2004-02-23 2006-11-22 Chugai Seiyaku Kabushiki Kaisha Heteroarylphenylurea derivative
WO2006049941A2 (en) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl ureas as cb1 antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DUMAS J: "PROTEIN KINASE INHIBITORS FROM THE UREA CLASS", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, vol. 5, no. 5, 1 January 2002 (2002-01-01), pages 718 - 727, XP009011493, ISSN: 1367-6733 *

Also Published As

Publication number Publication date
WO2008122667A2 (en) 2008-10-16
GB0706932D0 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
ZA201003928B (en) Thiazole derivatives used as pi 3 kinase inhibitors
IL224109A (en) Isoxazole derivatives for use as fungicides
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
WO2008101682A3 (en) Iminipyridine derivatives and their uses as microbiocides
ZA200904108B (en) Pyrido-pyrazine derivatives useful as herbicidal compounds
WO2008110355A8 (en) Quinoline derivatives as fungicides
PL2205562T3 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
SI2201012T1 (en) Pyrrološ2,3-dćpyrimidin derivatives as protein kinase b inhibitors
WO2008083252A3 (en) Methods of use for cyclopamine analogs
WO2009024342A3 (en) Novel microbiocides
IL204563A (en) Thiazole derivatives
ZA201002217B (en) 1,3-dihydroisoindole derivatives
EP1940843A4 (en) Unsaturated heterocyclic derivatives
WO2008151828A3 (en) Novel microbiocides
ZA201008657B (en) 4,5-dihydro-oxazol-2-yl derivatives
ZA200906462B (en) Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide
WO2008155666A3 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
PL2220060T3 (en) Tetrahydrobenzothiazole derivatives
WO2009003672A3 (en) Novel microbiocides
WO2008122667A3 (en) Ureylene derivatives
IL223327A0 (en) 5,6 or 7-substituted-s- (hetero) arylisoquinolinamine derivatives as antitumor agents
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
ZA200907389B (en) Fungicides phenyl-pyrimdinyl-amino derivatives
WO2009111028A8 (en) Aurora kinase inhibitors
HK1143978A (en) Thiazole derivatives used as pi 3 kinase inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08749535

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08749535

Country of ref document: EP

Kind code of ref document: A2